Your browser doesn't support javascript.
loading
Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.
Lorusso, Domenica; Danesi, Romano; Locati, Laura Deborah; Masi, Gianluca; De Giorgi, Ugo; Gadducci, Angiolo; Pignata, Sandro; Sabbatini, Roberto; Savarese, Antonella; Valabrega, Giorgio; Zamagni, Claudio; Colombo, Nicoletta.
Afiliação
  • Lorusso D; Department of Clinical Research Planning, Fondazione Policlinico Universitario A Gemelli Istituto di Ricerca e Cura a carattere scientifico (IRCCS), Rome, Italy.
  • Danesi R; Department of Life Science and Public Health, Catholic University of Sacred Heart, Rome, Italy.
  • Locati LD; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Masi G; Translational Oncology Unit, Istituto di Ricerca e Cura a carattere scientifico (IRCCS) Istituti Clinici Scientifici (ICS) Maugeri, Pavia, Italy.
  • De Giorgi U; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
  • Gadducci A; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Pignata S; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Sabbatini R; Department of Medical Oncology, Istituto di Ricerca e Cura a carattere scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST), Dino Amadori, Meldola, Italy.
  • Savarese A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
  • Valabrega G; Department of Urology and Gynecology, Istituto Nazionale Tumori Istituto di Ricerca e Cura a carattere scientifico (IRCCS) "Fondazione Giovanni Pascale", Naples, Italy.
  • Zamagni C; Department of Urology and Gynecology, Istituto Nazionale Tumori Istituto di Ricerca e Cura a carattere scientifico (IRCCS) "Fondazione Giovanni Pascale", Naples, Italy.
  • Colombo N; Division of Medical Oncology 1, Istituto di Ricerca e Cura a carattere scientifico (IRCCS) -Regina Elena National Cancer Institute, Rome, Italy.
Front Oncol ; 13: 1232476, 2023.
Article em En | MEDLINE | ID: mdl-37609387
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2022.979519.].
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article